These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9019842)

  • 1. [A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].
    Savenkov MP; Borshchevskaia MV; Gvozdkov AL; Semenova EN
    Ter Arkh; 1996; 68(8):8-12. PubMed ID: 9019842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
    Nilsen DW; Gøransson L; Larsen AI; Hetland O; Kierulf P
    Thromb Haemost; 1997 Jan; 77(1):57-61. PubMed ID: 9031450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of minidoses of heparin on the blood coagulation and thrombocytic links of hemostasis in myocardial infarct in middle-aged and elderly patients].
    Nechaev DD; Bochko II; Kuz'mina LF; Martynov IV; Khloponina NN
    Ter Arkh; 1987; 59(10):105-8. PubMed ID: 3433205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparins and venous thromboembolism: current practice and future directions.
    Prandoni P
    Thromb Haemost; 2001 Jul; 86(1):488-98. PubMed ID: 11487039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of Clexane (low-molecular-weight heparin) on the hemostatic system and on the incidence of postoperative thrombotic complications in gynecological cancer patients].
    Madzhuga AV; Somonova OV; Kononenko LP; Gorobets ES; Elizarova AL; Astakhova VM
    Anesteziol Reanimatol; 2000; (2):54-6. PubMed ID: 10833839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and tolerance of heparin-calcium at low doses in postinfarct ischemic cardiopathy].
    Melina D; Guerrera G; Melina G; Guerrera C
    Clin Ter; 1992 Dec; 141(12):447-56. PubMed ID: 1493666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Streptodecase-2 in the treatment of acute myocardial infarct, unstable stenocardia, thromboembolism and thrombosis].
    Butorov VN; Repinskaia NP; Demidova AV; Sysoeva NA; Kirichenko AA
    Ter Arkh; 1990; 62(8):21-6. PubMed ID: 2274864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
    Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
    Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Kearon C
    N Engl J Med; 1998 Jan; 338(2):129-30; author reply 131. PubMed ID: 9424582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.